Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

253 views

Visitors from

US 53%·

AU 33%·

IN 7%·

GB 2%·

FR 1%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

BiomX Presenting at Three Upcoming Investor Conferences

By: BiomX Inc. via Business Wire

February 24, 2022 at 08:00 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

2022 Aegis Virtual Conference on February 24, 2022

Chardan 4^th Annual Microbiome Medicines Summit on March 1, 2022

Oppenheimer & Co. 32^nd Annual Virtual Healthcare Conference on March 17, 2022

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer of BiomX, will present at the 2022 Aegis Virtual Conference on February 24, 2022, the Chardan 4^th Annual Microbiome Medicines Summit on March 1, 2022 and the Oppenheimer & Co. 32^nd Annual Healthcare Conference on March 17, 2022.

*2022 Aegis Virtual Conference – February 23-25, 2022*

Date & Time:		Thursday, March 24, 2:30 PM EST
Presenter:		Jonathan Solomon
Conference registration:		Link

*Chardan 4^th Annual Microbiome Medicines Summit – March 1, 2022*

Date & Time:		Tuesday, March 1, 8:30 AM EST
Presenter: Conference registration:		Jonathon Solomon Link

*Oppenheimer & Co. 32^nd Annual Healthcare Conference – March 15-17, 2022*

Date & Time:		Thursday, March 17, 2:00 PM EST
Presenter:		Jonathan Solomon
Conference registration:		Link

Live webcasts of presentations will also be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.

About BiomX Inc.

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.BiomX.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005117/en/

Contacts

BiomX Contacts

Investor Relations:

LifeSci Advisors, LLC

John Mullaly

(617)-698-9253

jmullaly@lifesciadvisors.com

BiomX, Inc.

Anat Primovich

Corporate Project Manager

+972 (50) 697-7228

anatp@biomx.com